Mardi Dier - Oct 14, 2022 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
CFO & Executive Vice President
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Oct 14, 2022
Transactions value $
-$65,421
Form type
4
Date filed
10/17/2022, 06:49 PM
Previous filing
Oct 14, 2022
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$65.4K -1.63K -2.38% $40.16 66.7K Oct 14, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.